Morgan Stanley reports a passive stake above 5% in Immunic (IMUX).
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
Morgan Stanley has reported a passive beneficial ownership of 704,244 shares of Immunic, Inc. (IMUX) common stock, which represents a 5.2% stake in the company. The filing indicates shared voting power over 702,419 shares and shared dispositive power over all 704,244 shares, with no sole voting or dispositive power reported.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.